Since its early days in the late 1990s, cryopreservation of ovarian tissue (OTC) has
developed from being an experimental procedure offered to a select few to being a standard
method of fertility preservation that is particularly relevant for young girls and adolescents
and women in need of urgent chemotherapy or radiation therapy in whom there is no time
for controlled ovarian stimulation and egg harvesting. Although some countries and centers
have been very active in developing and offering OTC to patients with cancer or other life …